Last Posted: Jan-27-2017 8AM
Last Posted: Jan 26, 2017
- Staying one step ahead of cancer, through genetics
C Danforth, Invitae Blog, 2016 - Anxiety and depression symptoms among women attending group-based patient education courses for hereditary breast and ovarian cancer.
Listøl Wenche et al. Hereditary cancer in clinical practice 2017 152 - Large, Prospective Analysis of the Reasons Patients Do Not Pursue BRCA Genetic Testing Following Genetic Counseling.
Hayden Sommer et al. Journal of genetic counseling 2017 Jan - Cancer Risk Information Sharing: The Experience of Individuals Receiving Genetic Counseling for BRCA1/2 Mutations.
Chopra Ishveen et al. Journal of health communication 2017 Jan 1-10 - A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes.
Buys Saundra S et al. Cancer 2017 Jan - Awareness and attitude regarding reproductive options of persons carrying a BRCA mutation and their partners.
Gietel-Habets J J G et al. Human reproduction (Oxford, England) 2017 Jan - Genomics and the 'Angelina Jolie effect'
Genomics Education UK, January 16, 2017 - How do BRCA1 and BRCA2 mutations cause cancer?
Mainstreaming Cancer Genetics, January 12, 2017 - Understanding Genetic Breast Cancer Risk: Processing Loci of the BRCA Gist Intelligent Tutoring System.
Wolfe Christopher R et al. Learning and individual differences 2016 Jul 49178-189 - Comparison between CaGene 5.1 and 6.0 for BRCA1/2 mutation prediction: a retrospective study of 150 BRCA1/2 genetic tests in 517 families with breast/ovarian cancer.
Antonucci Ivana et al. Journal of human genetics 2016 Dec - Previvors' Uncertainty Management Strategies for Hereditary Breast and Ovarian Cancer.
Dean Marleah et al. Health communication 2016 Dec 1-9 - BRCA mutation genetic testing implications in the United States.
Bayraktar Soley et al. Breast (Edinburgh, Scotland) 2016 Dec 31224-232 - BRCA Status Does Not Predict Survival for Young Patients With Breast Cancer
J Daley, Cancer Therapy Advisor, December 9, 2016 - Delivering widespread BRCA testing and PARP inhibition to patients with ovarian cancer.
George Angela et al. Nature reviews. Clinical oncology 2016 Dec - Population screening for BRCA1/BRCA2 founder mutations in Ashkenazi Jews: proactive recruitment compared with self-referral.
Lieberman Sari et al. Genetics in medicine : official journal of the American College of Medical Genetics 2016 Dec - Population screening for BRCA1/BRCA2 mutations: lessons from qualitative analysis of the screening experience.
Lieberman Sari et al. Genetics in medicine : official journal of the American College of Medical Genetics 2016 Dec
No hay comentarios:
Publicar un comentario